• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌相关成纤维细胞衍生的 FGF7 促进透明细胞肾细胞癌的进展和巨噬细胞浸润。

Cancer-Associated Fibroblast-Derived FGF7 Promotes Clear Cell Renal Cell Carcinoma Progression and Macrophage Infiltration.

机构信息

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China.

Department of Genetics, Xuzhou Medical University, Xuzhou 221004, China.

出版信息

Cells. 2024 Nov 5;13(22):1824. doi: 10.3390/cells13221824.

DOI:10.3390/cells13221824
PMID:39594574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11593278/
Abstract

As the predominant stromal cells in the ccRCC surrounding environment, cancer-associated fibroblasts (CAFs) have been established as supportive of tumor growth. However, the detailed molecular mechanisms underlying the supporting role of CAFs in ccRCC have not been well characterized. Evidence from the clustering consensus analysis, single-cell analysis, and the experimental results illustrate that CAF-derived FGF7 plays a crucial role as a signaling mediator between CAFs and ccRCC tumor cells. Mechanistically, CAF-derived FGF7 triggers AKT activation to promote cell growth and cell invasion of ccRCC tumor cells. As a response, ccRCC tumor cells stimulate STAT3-mediated transcriptional regulation, directly increasing FGF7 expression at the chromatin level in CAFs. Moreover, there exists a positive clinical correlation between the abundance of CAFs, FGF7 expression, and the infiltration of M2 type macrophages. The RENCA in vivo mouse model also confirmed that FGF7 depletion could impede RCC development by reducing the recruitment of M2 type macrophages. Overall, this study delineates a key signaling axis governing the crosstalk between CAFs and ccRCC tumor cells, highlighting FGF7 as a promising therapeutic target of ccRCC.

摘要

作为 ccRCC 周围环境中的主要基质细胞,癌症相关成纤维细胞 (CAFs) 已被确定为支持肿瘤生长的细胞。然而,CAFs 在 ccRCC 中支持作用的详细分子机制尚未得到很好的描述。聚类共识分析、单细胞分析和实验结果的证据表明,CAF 衍生的 FGF7 作为 CAFs 和 ccRCC 肿瘤细胞之间的信号介质发挥着关键作用。从机制上讲,CAF 衍生的 FGF7 触发 AKT 激活,促进 ccRCC 肿瘤细胞的生长和细胞侵袭。作为一种反应,ccRCC 肿瘤细胞刺激 STAT3 介导的转录调节,直接增加 CAFs 染色质水平上的 FGF7 表达。此外,CAFs 的丰度、FGF7 表达和 M2 型巨噬细胞的浸润之间存在正相关的临床相关性。RENCA 体内小鼠模型也证实,通过减少 M2 型巨噬细胞的募集,FGF7 的耗竭可以阻碍 RCC 的发展。总的来说,这项研究描绘了一个关键的信号轴,它控制着 CAFs 和 ccRCC 肿瘤细胞之间的串扰,突出了 FGF7 作为 ccRCC 有前途的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/c55668efdd45/cells-13-01824-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/bc6bb2207de8/cells-13-01824-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/03d65db21009/cells-13-01824-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/5d66e77f4ce7/cells-13-01824-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/2c3bba85cbf9/cells-13-01824-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/f0e72281f4f3/cells-13-01824-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/c55668efdd45/cells-13-01824-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/bc6bb2207de8/cells-13-01824-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/03d65db21009/cells-13-01824-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/5d66e77f4ce7/cells-13-01824-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/2c3bba85cbf9/cells-13-01824-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/f0e72281f4f3/cells-13-01824-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d87f/11593278/c55668efdd45/cells-13-01824-g006.jpg

相似文献

1
Cancer-Associated Fibroblast-Derived FGF7 Promotes Clear Cell Renal Cell Carcinoma Progression and Macrophage Infiltration.癌相关成纤维细胞衍生的 FGF7 促进透明细胞肾细胞癌的进展和巨噬细胞浸润。
Cells. 2024 Nov 5;13(22):1824. doi: 10.3390/cells13221824.
2
LDHA-mediated M2-type macrophage polarization via tumor-derived exosomal EPHA2 promotes renal cell carcinoma progression.LDHA 通过肿瘤来源的外泌体 EphA2 介导 M2 型巨噬细胞极化促进肾细胞癌进展。
Mol Carcinog. 2024 Aug;63(8):1486-1499. doi: 10.1002/mc.23737. Epub 2024 May 23.
3
Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.肿瘤相关成纤维细胞来源的外泌体递送 miR-224-5p 促进肾透明细胞癌进展。
Comput Math Methods Med. 2021 May 24;2021:5517747. doi: 10.1155/2021/5517747. eCollection 2021.
4
Crosstalk between GBP2 and M2 macrophage promotes the ccRCC progression.GBP2 与 M2 巨噬细胞的串扰促进 ccRCC 的进展。
Cancer Sci. 2024 Nov;115(11):3570-3586. doi: 10.1111/cas.16287. Epub 2024 Sep 2.
5
VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.VHL 突变介导的 SALL4 过表达通过 Akt/GSK-3β 信号通路促进肾透明细胞癌的发生和血管生成。
J Exp Clin Cancer Res. 2020 Jun 8;39(1):104. doi: 10.1186/s13046-020-01609-8.
6
Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapy.肾细胞癌中的癌相关成纤维细胞:对预后和抗血管生成治疗耐药性的影响。
BJU Int. 2022 Jan;129(1):80-92. doi: 10.1111/bju.15506. Epub 2021 Aug 8.
7
MYBL2 promotes proliferation of clear cell renal cell carcinoma by regulating TOP2A and activating AKT/mTOR signaling pathway.MYBL2通过调节TOP2A和激活AKT/mTOR信号通路促进透明细胞肾细胞癌的增殖。
FASEB J. 2025 Jan 31;39(2):e70330. doi: 10.1096/fj.202401910R.
8
Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.癌症相关成纤维细胞分泌的 FGF7 作为卵巢癌进展的促进剂。
J Transl Med. 2024 Mar 15;22(1):280. doi: 10.1186/s12967-024-05085-y.
9
ISG15 promotes tumor progression via IL6/JAK2/STAT3 signaling pathway in ccRCC.ISG15 通过 IL6/JAK2/STAT3 信号通路促进 ccRCC 肿瘤进展。
Clin Exp Med. 2024 Jun 29;24(1):140. doi: 10.1007/s10238-024-01414-z.
10
Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3.来自透明细胞肾细胞癌的外泌体 AP000439.2 通过激活 STAT3 诱导 M2 巨噬细胞极化促进肿瘤进展。
Cell Commun Signal. 2022 Sep 24;20(1):152. doi: 10.1186/s12964-022-00957-6.

本文引用的文献

1
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions.成纤维细胞生长因子受体靶向治疗药物:临床活性、耐药机制及新方向。
Nat Rev Clin Oncol. 2024 Apr;21(4):312-329. doi: 10.1038/s41571-024-00869-z. Epub 2024 Feb 29.
2
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease.mTOR(哺乳动物雷帕霉素靶蛋白)信号通路在人类健康和疾病中的多方面作用。
Signal Transduct Target Ther. 2023 Oct 2;8(1):375. doi: 10.1038/s41392-023-01608-z.
3
Single-cell transcriptome analysis revealing the intratumoral heterogeneity of ccRCC and validation of MT2A in pathogenesis.
单细胞转录组分析揭示 ccRCC 的肿瘤内异质性及 MT2A 在发病机制中的验证。
Funct Integr Genomics. 2023 Sep 15;23(4):300. doi: 10.1007/s10142-023-01225-7.
4
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.PI3K/AKT/mTOR 信号转导通路与癌症的靶向治疗。
Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6.
5
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study.帕博利珠单抗联合阿昔替尼与舒尼替尼作为晚期肾细胞癌一线治疗的比较:3期KEYNOTE-426研究的43个月随访
Eur Urol. 2023 Nov;84(5):449-454. doi: 10.1016/j.eururo.2023.06.006. Epub 2023 Jul 25.
6
Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor.透明细胞肾细胞癌对酪氨酸激酶抑制剂反应的蛋白质基因组学研究
Nat Commun. 2023 Jul 17;14(1):4274. doi: 10.1038/s41467-023-39981-6.
7
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations.RLY-4008,首个具有活性的高度选择性 FGFR2 抑制剂,可作用于 FGFR2 改变和耐药突变。
Cancer Discov. 2023 Sep 6;13(9):2012-2031. doi: 10.1158/2159-8290.CD-23-0475.
8
PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis.PI3K/AKT/mTOR 失调与肾癌代谢途径重编程:与 VHL/HIF 轴的串扰。
Int J Mol Sci. 2023 May 7;24(9):8391. doi: 10.3390/ijms24098391.
9
The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌的肿瘤免疫微环境。
Int J Mol Sci. 2023 Apr 27;24(9):7946. doi: 10.3390/ijms24097946.
10
Vascular mimicry induced by mA mediated IGFL2-AS1/AR axis contributes to pazopanib resistance in clear cell renal cell carcinoma.由mA介导的IGFL2-AS1/AR轴诱导的血管拟态促进透明细胞肾细胞癌对帕唑帕尼的耐药性。
Cell Death Discov. 2023 Apr 11;9(1):121. doi: 10.1038/s41420-023-01423-z.